Variant report
Variant | esv3442014 |
---|---|
Chromosome Location | chr9:104256581-104258879 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs61396182 | chr9:104257859-104257860 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs10125893 | chr9:104257866-104257867 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs535996699 | chr9:104257876-104257877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188102482 | chr9:104257883-104257884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192934913 | chr9:104257886-104257887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56682764 | chr9:104257916-104257917 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs184244129 | chr9:104257923-104257924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs61685305 | chr9:104257954-104257955 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs554724063 | chr9:104257987-104257988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568181249 | chr9:104257988-104257989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565274145 | chr9:104257995-104257996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189439402 | chr9:104258095-104258096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34345182 | chr9:104258110-104258111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs72743387 | chr9:104258116-104258117 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs372836892 | chr9:104258135-104258136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565940173 | chr9:104258169-104258170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559025342 | chr9:104258226-104258227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572480041 | chr9:104258227-104258228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541187486 | chr9:104258268-104258269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555643819 | chr9:104258291-104258292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561495092 | chr9:104258315-104258316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192441143 | chr9:104258354-104258355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557706242 | chr9:104258358-104258359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs148099964 | chr9:104258360-104258361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149929392 | chr9:104258384-104258385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375386013 | chr9:104258422-104258423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543564092 | chr9:104258486-104258487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145038606 | chr9:104258491-104258492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs532703958 | chr9:104258496-104258497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111515521 | chr9:104258531-104258532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367762149 | chr9:104258532-104258533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551735579 | chr9:104258540-104258541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565564800 | chr9:104258568-104258569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183769009 | chr9:104258626-104258627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547990142 | chr9:104258636-104258637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568202108 | chr9:104258657-104258658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189173325 | chr9:104258666-104258667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7031385 | chr9:104258731-104258732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs113547541 | chr9:104258736-104258737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557234768 | chr9:104258749-104258750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570742821 | chr9:104258753-104258754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142227059 | chr9:104258754-104258755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs180700884 | chr9:104258783-104258784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369486468 | chr9:104258810-104258811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186374266 | chr9:104258830-104258831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189701310 | chr9:104258878-104258879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:104257800-104258400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr9:104257800-104258400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr9:104257800-104258400 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr9:104257800-104258400 | Enhancers | NHEK | skin |
5 | chr9:104258200-104258400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr9:104258200-104258600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr9:104258200-104258600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr9:104258200-104258600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:104258200-104258600 | Enhancers | Fetal Lung | lung |
10 | chr9:104258200-104258600 | Enhancers | A549 | lung |
11 | chr9:104258600-104260400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |